Consistent with those findings, our study found that miR-181a inhibited both the GS and RTE injury in CKD, which was supported by an apparent decrease in the cell apoptosis rate and the levels of ROS, MDA, IL-1β, IL-6, and TNF-α in the miR-181a mimic group. The gene discussed is IL6; the disease is chronic kidney disease.